Perspective Therapeutics (CATX)

• Market cap: $166M
• 1 day: 5.38%
• 5 days: 10.85%
• 1 month: -18.12%
• 3 months: -30.47%
• 6 months: -8.91%
• Year to date: -29%
• 1 year: -45.98%
• 5 years: -37.33%
• 10 years: -80.25%
• Sector: Healthcare
• Industry: Medical Instruments & Supplies

About: Perspective Therapeutics Inc is a radiopharmaceutical development company that is pioneering advanced treatment applications for cancers throughout the body. The Company has a proprietary technology that utilizes the alpha-emitting isotope Lead-212 (212Pb) to deliver powerful radiation specifically to cancer cells via specialized targeting moieties.

Employees: 140